| OVERALL SAMPLE (n = 168) | |||||
| Average age: 70.60 years (range = 47 - 92) | |||||
| DM | Yes: 16.7% | No: 83.3% |
|
|
|
| PAH | Yes: 53.6% | No: 46.4% |
|
|
|
| DLP | Yes: 37% | No 63% |
|
|
|
| Statins | Yes: 30.3% | No: 69.7% |
|
|
|
| Gleason | G6: 13.6% | G7: 29.9% | G8: 26.5% | G9: 24.5% | G10: 5.4% |
| T | T1: 0.9% | T2: 22.3% | T3: 55.4% | T4: 21.4% |
|
| N | N0: 60.7% | N1: 29.9% | N2: 5.6% | N3: 3.7% |
|
| M | M0: 49.1% | M1a: 5% | M1b: 46% |
|
|
| Risk | Low: 2.4% | Medium: 7.1% | High: 81.5% |
|
|
| 1st Treatment | RT: 25.5% | PRL: 14.5% | HT: 46.1% | AA: 10.3% | CT: 2.4% |